Last updated on December 2015

A Phase 2 Study of On-demand Therapy With Clomipramine and Sildenafil Combination in Premature Ejaculation


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Premature Ejaculation
  • Age: Between 19 - 65 Years
  • Gender: Male
  • Other:
    Korean male aged between 19 and 65
    Both patient and his partner given their informed and written consents
    Patient who has persisted for at least 6 months and is willing to retain the
    relationship during this study
    Patient diagnosed with premature ejaculation according to DSM-V
    Patient whose score in PEDT (Korean version) is 11 and more
    Patient who are willing to try 4 and more intercourse attempts for Run-in period and
    he has experienced 75%-100% of the IELT within one minute or less of vaginal
    penetration
    Patient whose personal distress in PEP is 'moderate' and over.
    Patient who is willing to participate in the study by the end and are cooperative
    (trying 4 and more intercourse attempts between each visit and able to postpone
    cheduled elective surgery)
    Patient who is willing to complete a patient diary and questionnaires

You may not be eligible for this study if the following are true:

  • Patient who has a medical history including neurological disorders, infectious
    diseases, damage, surgery or medication history and that is judged to be related to
    premature ejaculation
    Patient who has participated into other trials within 90 days before this study
    Patient who is in a unstable medical condition or has alcohol/drug abuse in recent 6
    months
    Patient whose female partner is less interested in sexual intercourse or has a sexual
    disorder
    Patient whose female partner is pregnant
    Patient whose female partner of childbearing age is not willing to use proper birth
    control
    Patient whose IIEF-EF score is 25 and less
    Medical history of convulsive diseases, mental diseases, E.C.T (Electroconvulsive
    hock Treatment), glaucoma
    Patient who has taken concomitantly prohibited medicines before the study and who is
    not willing to stop the medications for appropriate wash-out period

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.